Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123002402 | 12300240 | 2 | F | 201012 | 20160809 | 20160425 | 20160815 | EXP | DE-PFIZER INC-2016217584 | PFIZER | 63.00 | YR | M | Y | 114.00000 | KG | 20160815 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123002402 | 12300240 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY, 0-0-1 (IN THE EVENING) | Y | 20702 | 40 | MG | QD | ||||||
| 123002402 | 12300240 | 2 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Y | 20702 | |||||||||||
| 123002402 | 12300240 | 3 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, 1X/DAY, 0-0-1 (IN THE EVENING) | Y | 0 | 40 | MG | QD | ||||||
| 123002402 | 12300240 | 4 | SS | FLUVASTATIN | FLUVASTATIN SODIUM | 1 | Oral | 40 MG, 1X/DAY, 0-0-1 (IN THE EVENING) | Y | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123002402 | 12300240 | 1 | Coronary artery disease |
| 123002402 | 12300240 | 2 | Hypercholesterolaemia |
| 123002402 | 12300240 | 3 | Hypercholesterolaemia |
| 123002402 | 12300240 | 4 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123002402 | 12300240 | LT |
| 123002402 | 12300240 | OT |
| 123002402 | 12300240 | HO |
| 123002402 | 12300240 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123002402 | 12300240 | Alveolitis | |
| 123002402 | 12300240 | Atypical pneumonia | |
| 123002402 | 12300240 | Dyspnoea | |
| 123002402 | 12300240 | Dyspnoea at rest | |
| 123002402 | 12300240 | Myopathy | |
| 123002402 | 12300240 | Tendon rupture | |
| 123002402 | 12300240 | Walking disability |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123002402 | 12300240 | 1 | 201306 | 201308 | 0 | |
| 123002402 | 12300240 | 3 | 201010 | 0 | ||
| 123002402 | 12300240 | 4 | 201010 | 201012 | 0 |